SCOTT WILLIAM MEYERS M.D.
Prescription History 1285647586
Dermatology - MOHS-Micrographic Surgery in Tulsa, OK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SCOTT WILLIAM MEYERS M.D., an active MOHS-Micrographic Surgery specialist practicing in Tulsa, OK. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 492 documented patient claims. Among these therapy options, the most frequently utilized medication is Cephalexin, which accounts for 352 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OK PrescribersVs. OK Avg |
|---|---|---|---|
| Cephalexin | 352 | $4.61▼ below OK avg | ▲ More than typical |
About Cephalexin: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. In 2024, this provider wrote 352 Medicare prescriptions for Cephalexin, about 11 times the volume of the typical Oklahoma prescriber of this medication (32.2). Medicare paid an average of $4.61 per fill, versus $7.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 353 30-Day Fills standardized to 30-day supplies 2,625 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 90 | $4.78▼ below OK avg | ▲ More than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 90 Medicare prescriptions for Azithromycin, about 2.5 times the volume of the typical Oklahoma prescriber of this medication (36.2). Medicare paid an average of $4.78 per fill, versus $6.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 90 30-Day Fills standardized to 30-day supplies 448 Days of Medication total across all patients in 2024 | |||
| Imiquimod | 20 | $23.70▼ below OK avg | ▼ Less than typical |
About Imiquimod: This medication is used to treat certain types of growths on the skin. Show more ▾ These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor. A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial BASAL CELL CARCINOMA; and ACTINIC KERATOSIS. In 2024, this provider wrote 20 Medicare prescriptions for Imiquimod, about 65% of the volume of the typical Oklahoma prescriber of this medication (31). Medicare paid an average of $23.70 per fill, versus $32.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 24.8 30-Day Fills standardized to 30-day supplies 712 Days of Medication total across all patients in 2024 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $7.54▼ below OK avg | ▼ Less than typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2024, this provider wrote 16 Medicare prescriptions for Hydrocodone-Acetaminophen, about 12% of the volume of the typical Oklahoma prescriber of this medication (138.7). Medicare paid an average of $7.54 per fill, versus $24.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 16 30-Day Fills standardized to 30-day supplies 66 Days of Medication total across all patients in 2024 | |||
| Fluorouracil | 14 | $69.72 | ▼ Less than typical |
About Fluorouracil: This medication is used on the skin to treat pre-cancerous and cancerous skin growths. Show more ▾ Fluorouracil belongs to a class of medications known as anti-metabolites. It works by blocking the growth of abnormal cells that cause the skin condition. A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. In 2024, this provider wrote 14 Medicare prescriptions for Fluorouracil, about a third of the volume of the typical Oklahoma prescriber of this medication (39.9). Medicare paid an average of $69.72 per fill, versus $68.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14.7 30-Day Fills standardized to 30-day supplies 413 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for SCOTT WILLIAM MEYERS M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall MOHS-Micrographic Surgery prescribing approach at this Tulsa, OK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
